Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,329.80 INR | +0.19% |
|
-2.53% | -0.90% |
Jun. 30 | Deals of the Day-Mergers and acquisitions | RE |
Jun. 30 | Sector Update: Financial Stocks Advance Premarket Monday | MT |
Chart calendar Torrent Pharmaceuticals Limited
5bb666.Jd1WZQNDFBpJ4h5w0m-Tdp7g8El4LcqbmIk-QhdV8Vk.Q5gfLk4EQV0qmisvoCPKONaJoTo0eoLtzdxGcVIAmmlonhMnTgxgfzG1Lg~9476f9c6b855888fbce3945d8d75a1b4
Upcoming events on Torrent Pharmaceuticals Limited
Past events on Torrent Pharmaceuticals Limited
Past dividends on Torrent Pharmaceuticals Limited
2025-06-19 | Final Payment 6 INR |
2025-01-30 | Interim Payment 26 INR |
2024-06-20 | Final Payment 6 INR |
2024-02-11 | Interim Payment 22 INR |
2023-06-22 | Final Payment 8 INR |
2023-02-02 | Interim Payment 14 INR |
2022-06-02 | Bonus Payment 15 INR |
2022-06-02 | Final Payment 8 INR |
2022-02-01 | Interim Payment 25 INR |
2021-06-16 | Final Payment 15 INR |
2021-02-14 | Interim Payment 20 INR |
2020-03-17 | Bonus Payment 15 INR |
2020-03-17 | Interim Payment 17 INR |
2019-06-12 | Final Payment 4 INR |
2019-02-05 | Interim Payment 13 INR |
2018-06-17 | Final Payment 5 INR |
2018-02-14 | Interim Payment 9 INR |
2017-06-18 | Final Payment 4 INR |
2017-02-09 | Interim Payment 10 INR |
2016-03-15 | Bonus Payment 15 INR |
Annual results
Fiscal Period | March | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 96 200 95 580 0.65% | 107 280 108 171 -0.82% | 115 160 115 832 -0.58% | 129 499 | 145 276 | 162 225 |
EBITDA Million INR | Released Forecast Spread | 28 420 28 213 0.73% | 33 680 33 792 -0.33% | 37 210 37 541 -0.88% | 42 966 | 49 194 | 55 507 |
EBIT Million INR | Released Forecast Spread | 21 350 21 082 1.27% | 26 480 25 728 2.92% | 29 260 29 668 -1.37% | 34 913 | 40 869 | 46 695 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 18 470 18 900 -2.27% | 23 520 23 162 1.55% | 26 730 27 668 -3.39% | 33 678 | 40 522 | 46 606 |
Net income Million INR | Released Forecast Spread | 12 450 12 898 -3.47% | 16 560 16 473 0.53% | 19 110 19 496 -1.98% | 24 949 | 30 228 | 35 160 |
EPS INR | Released Forecast Spread | 26,8 38,1 -29.63% | 48,9 48,1 1.76% | 56,5 57,6 -2.03% | 73,3 | 88,6 | 103 |
Announcement Date | 30/05/23 | 24/05/24 | 20/05/25 | - |
Quarterly results
Fiscal Period | March | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 26 600 26 329 1.03% | 27 320 27 505 -0.67% | 27 450 27 836 -1.39% | 28 590 28 886 -1.02% | 28 890 29 624 -2.48% | 28 090 29 857 -5.92% | 29 590 29 954 -1.22% | 31 712 | 32 377 | 32 291 | 32 966 |
EBITDA Million INR | Released Forecast Spread | 8 250 8 124 1.55% | 8 690 8 597 1.08% | 8 830 8 895 -0.73% | 9 040 9 134 -1.03% | 9 390 9 541 -1.58% | 9 140 9 770 -6.45% | 9 640 9 805 -1.69% | 10 539 | 10 760 | 10 659 | 10 768 |
EBIT Million INR | Released Forecast Spread | 6 240 6 087 2.52% | 6 560 6 507 0.82% | 6 800 6 782 0.26% | 7 070 7 185 -1.6% | 7 410 7 556 -1.93% | 7 150 7 752 -7.77% | 7 630 7 988 -4.48% | 8 359 | 8 440 | 8 634 | 8 739 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 5 590 5 592 -0.03% | 6 310 6 014 4.93% | 6 310 6 426 -1.8% | 6 560 6 702 -2.12% | 6 610 6 956 -4.97% | 6 910 7 394 -6.55% | 6 650 7 460 -10.86% | 7 944 | 8 178 | 8 098 | 8 169 |
Net income Million INR | Released Forecast Spread | 3 860 3 892 -0.83% | 4 430 4 173 6.17% | 4 490 4 570 -1.75% | 4 570 4 713 -3.03% | 4 530 4 922 -7.96% | 5 030 5 112 -1.6% | 4 980 5 208 -4.38% | 6 019 | 6 035 | 6 017 | 6 037 |
EPS INR | Released Forecast Spread | 11,4 11,4 -0.38% | 13,1 12,5 4.74% | 13,3 13,2 0.28% | 13,5 13,9 -2.57% | 13,4 14,5 -7.65% | 14,9 15,4 -3.09% | 14,7 15,7 -6.01% | 18,7 | |||
Announcement Date | 23/10/23 | 02/02/24 | 24/05/24 | 23/07/24 | 25/10/24 | 24/01/25 | 20/05/25 | - | - | - | - |
2025-07-09 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2025-07-15 | GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-16 06:45 am | JOHNSON & JOHNSON: Q2 2025 Earnings Release |
2025-07-16 | NOVARTIS AG: Q2 2025 Earnings Release |
2025-07-17 01:00 am | CAMURUS AB: Q2 2025 Earnings Release |
2025-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-18 05:00 am | ORION OYJ: Q2 2025 Earnings Release |
2025-07-22 | DR. REDDY'S LABORATORIES LIMITED: Q1 2026 Earnings Release |
2025-07-22 | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected) |
2025-07-22 | TILRAY BRANDS, INC.: Q4 2025 Earnings Release (Projected) |
Past sector events for Torrent Pharmaceuticals Limited
2025-07-02 04:08 am | ONENESS BIOTECH CO., LTD.: June 2025 Sales and Revenue Release |
2025-06-17 11:45 am | MEDINCELL S.A.: Q4 2025 Earnings Release |
2025-06-10 04:38 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-10 01:42 am | CENTER LABORATORIES, INC.: May 2025 Sales and Revenue Release |
2025-06-10 01:37 am | SYNMOSA BIOPHARMA CORPORATION: May 2025 Sales and Revenue Release |
2025-06-09 04:48 am | YUNGSHIN GLOBAL HOLDING CORPORATION: May 2025 Sales and Revenue Release |
2025-06-08 08:01 pm | BORA PHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-06 04:47 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-05 04:37 am | TTY BIOPHARM COMPANY LIMITED: May 2025 Sales and Revenue Release |
2025-06-03 04:35 am | ONENESS BIOTECH CO., LTD.: May 2025 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TORNTPHARM Stock
- Calendar Torrent Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions